Compile Data Set for Download or QSAR
Report error Found 13 Enz. Inhib. hit(s) with all data for entry = 2586
TargetOxysterols receptor LXR-beta(Human)
Ralexar Therapeutics

US Patent
LigandPNGBDBM372421(US10246419, Compound 4)
Affinity DataEC50: <1.00E+3nMAssay Description:For transient transfection of HEK 293 cells, 6×103 cells are plated into 96-well dishes. Each well is transfected with 25 ng 5×UAS-luciferase reporte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
Go to US Patent

TargetOxysterols receptor LXR-beta(Human)
Ralexar Therapeutics

US Patent
LigandPNGBDBM372422(US10246419, Compound 5)
Affinity DataEC50: <1.00E+3nMAssay Description:For transient transfection of HEK 293 cells, 6×103 cells are plated into 96-well dishes. Each well is transfected with 25 ng 5×UAS-luciferase reporte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
Go to US Patent

TargetOxysterols receptor LXR-beta(Human)
Ralexar Therapeutics

US Patent
LigandPNGBDBM372423(US10246419, Compound 6)
Affinity DataEC50: <1.00E+3nMAssay Description:For transient transfection of HEK 293 cells, 6×103 cells are plated into 96-well dishes. Each well is transfected with 25 ng 5×UAS-luciferase reporte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
Go to US Patent

TargetOxysterols receptor LXR-beta(Human)
Ralexar Therapeutics

US Patent
LigandPNGBDBM372424(US10246419, Compound 10 | US10246419, Compound 7)
Affinity DataEC50: <1.00E+3nMAssay Description:For transient transfection of HEK 293 cells, 6×103 cells are plated into 96-well dishes. Each well is transfected with 25 ng 5×UAS-luciferase reporte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
Go to US Patent

TargetOxysterols receptor LXR-beta(Human)
Ralexar Therapeutics

US Patent
LigandPNGBDBM372425(US10246419, Compound 8)
Affinity DataEC50:  5.50E+3nMAssay Description:For transient transfection of HEK 293 cells, 6×103 cells are plated into 96-well dishes. Each well is transfected with 25 ng 5×UAS-luciferase reporte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
Go to US Patent

TargetOxysterols receptor LXR-beta(Human)
Ralexar Therapeutics

US Patent
LigandPNGBDBM372426(US10246419, Compound 9)
Affinity DataEC50:  5.50E+3nMAssay Description:For transient transfection of HEK 293 cells, 6×103 cells are plated into 96-well dishes. Each well is transfected with 25 ng 5×UAS-luciferase reporte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
Go to US Patent

TargetOxysterols receptor LXR-beta(Human)
Ralexar Therapeutics

US Patent
LigandPNGBDBM372424(US10246419, Compound 10 | US10246419, Compound 7)
Affinity DataEC50:  5.50E+3nMAssay Description:For transient transfection of HEK 293 cells, 6×103 cells are plated into 96-well dishes. Each well is transfected with 25 ng 5×UAS-luciferase reporte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
Go to US Patent

TargetOxysterols receptor LXR-beta(Human)
Ralexar Therapeutics

US Patent
LigandPNGBDBM372428(US10246419, Compound 11)
Affinity DataEC50:  5.50E+3nMAssay Description:For transient transfection of HEK 293 cells, 6×103 cells are plated into 96-well dishes. Each well is transfected with 25 ng 5×UAS-luciferase reporte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
Go to US Patent

TargetOxysterols receptor LXR-beta(Human)
Ralexar Therapeutics

US Patent
LigandPNGBDBM372429(US10246419, Compound 12)
Affinity DataEC50:  5.50E+3nMAssay Description:For transient transfection of HEK 293 cells, 6×103 cells are plated into 96-well dishes. Each well is transfected with 25 ng 5×UAS-luciferase reporte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
Go to US Patent

TargetOxysterols receptor LXR-beta(Human)
Ralexar Therapeutics

US Patent
LigandPNGBDBM372430(US10246419, Compound 18 | 1-(cyclopropylmethyl)- 5...)
Affinity DataEC50: <1.00E+3nMAssay Description:For transient transfection of HEK 293 cells, 6×103 cells are plated into 96-well dishes. Each well is transfected with 25 ng 5×UAS-luciferase reporte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
Go to US Patent

TargetOxysterols receptor LXR-beta(Human)
Ralexar Therapeutics

US Patent
LigandPNGBDBM372431(US10246419, Compound 19 | 1-(sec-butyl)-5-(3'- (me...)
Affinity DataEC50: >1.00E+4nMAssay Description:For transient transfection of HEK 293 cells, 6×103 cells are plated into 96-well dishes. Each well is transfected with 25 ng 5×UAS-luciferase reporte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
Go to US Patent

TargetOxysterols receptor LXR-beta(Human)
Ralexar Therapeutics

US Patent
LigandPNGBDBM372432(US10246419, Compound 20 | 1-cyclohexyl-5-(3'- (met...)
Affinity DataEC50: >1.00E+4nMAssay Description:For transient transfection of HEK 293 cells, 6×103 cells are plated into 96-well dishes. Each well is transfected with 25 ng 5×UAS-luciferase reporte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
Go to US Patent

TargetOxysterols receptor LXR-beta(Human)
Ralexar Therapeutics

US Patent
LigandPNGBDBM372433(US10246419, Compound 21)
Affinity DataEC50: <1.00E+3nMAssay Description:For transient transfection of HEK 293 cells, 6×103 cells are plated into 96-well dishes. Each well is transfected with 25 ng 5×UAS-luciferase reporte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
Go to US Patent